Related Experiment Video
Updated: Aug 8, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Interferon-gamma-induced epithelial ICAM-1 expression and monocyte adhesion. Involvement of protein kinase
Ya-Jen Chang1, Michael J Holtzman, Ching-Chow Chen
1Department of Pharmacology, College of Medicine, National Taiwan University, No. 1 Jen-Ai Road, 1st Section, Taipei 10018, Taiwan.
Insights
Interferon-gamma (IFN-gamma) increases ICAM-1 expression and U937 cell adhesion in NCI-H292 cells. This pathway involves tyrosine kinases, PLC-gamma2, PKC-alpha, c-Src, STAT1alpha, and the GAS element in the ICAM-1 promoter.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Intercellular adhesion molecule-1 (ICAM-1) plays a crucial role in immune cell interactions.
- Interferon-gamma (IFN-gamma) is a key cytokine involved in immune responses.
- Understanding the signaling pathways regulating ICAM-1 expression is vital for immune modulation.
Purpose of the Study:
- To elucidate the molecular mechanisms by which IFN-gamma induces ICAM-1 expression in NCI-H292 epithelial cells.
- To identify the key signaling molecules and pathways involved in IFN-gamma-mediated ICAM-1 upregulation.
- To investigate the role of tyrosine kinases, phospholipase C, and protein kinase C in this process.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) and immunofluorescence staining to assess ICAM-1 expression.
- Use of specific inhibitors for tyrosine kinases, Src family, phosphatidylinositol-phospholipase C (PLC), and protein kinase C (PKC).
- Reporter gene assays (luciferase) with wild-type and mutant ICAM-1 promoter constructs, electrophoretic gel mobility shift assays (EMSA), and kinase assays.
Main Results:
- IFN-gamma significantly increased ICAM-1 expression and U937 cell adhesion to NCI-H292 cells.
- Tyrosine kinase inhibitors, Src inhibitor PP2, PLC inhibitor U73122, and PKC inhibitors (staurosporine, Ro 31-8220) attenuated IFN-gamma-induced ICAM-1 expression.
- IFN-gamma and TPA (PKC activator) enhanced ICAM-1 promoter activity via GAS and NF-kappaB sites, involving STAT1alpha activation. Both IFN-gamma and TPA activated c-Src and Lyn kinases.
- Cotransfection studies indicated that PLC-gamma2, PKCalpha, c-Src, JAK1, and STAT1 are essential components of the signaling cascade.
Conclusions:
- IFN-gamma induces ICAM-1 expression and subsequent monocyte adhesion in NCI-H292 cells through a signaling pathway involving tyrosine kinases, PLC-gamma2, PKC-alpha, c-Src/Lyn, STAT1alpha, and the GAS element of the ICAM-1 promoter.
- PKC activation is downstream of tyrosine kinase and PLC-gamma2 activation.
- This study elucidates a critical signaling cascade regulating ICAM-1 expression in epithelial cells, relevant to inflammatory and immune responses.
Abstract:
Interferon-gamma (IFN-gamma) induced intercellular adhesion molecule-1 (ICAM-1) expression in human NCI-H292 epithelial cells, as shown by enzyme-linked immunosorbent assay and immunofluorescence staining. The enhanced ICAM-1 expression resulted in increased adhesion of U937 cells to NCI-H292 cells. Tyrosine kinase inhibitors (genistein or herbimycin), Src family inhibitor (PP2), or a phosphatidylinositol-phospholipase C inhibitor (U73122) attenuated the IFN-gamma-induced ICAM-1 expression. Protein kinase C (PKC) inhibitors (staurosporine or Ro 31-8220) also inhibited IFN-gamma-induced response. 12-O-Tetradecanoylphorbol-13-acetate (TPA), a PKC activator, stimulated ICAM-1 expression; this effect was inhibited by tyrosine kinase or Src inhibitor. ICAM-1 promoter activity was enhanced by IFN-gamma and TPA in cells transfected with pIC339-Luc, containing the downstream NF-kappaB and gamma-activated site (GAS) sites, but not in cells transfected with GAS-deletion mutant, pIC135 (DeltaAP2). Electrophoretic gel mobility shift assay demonstrated that GAS-binding complexes in IFN-gamma-stimulated cells contained STAT1alpha. The IFN-gamma-induced ICAM-1 promoter activity was inhibited by tyrosine kinase inhibitors, a phosphatidylinositol-phospholipase C inhibitor, or PKC inhibitors, and the TPA-induced ICAM-1 promoter activity was also inhibited by tyrosine kinase inhibitors. Cotransfection with a PLC-gamma2 mutant inhibited IFN-gamma- but not TPA-induced ICAM-1 promoter activity. However, cotransfection with dominant negative mutants of PKCalpha or c-Src inhibited both IFN-gamma- and TPA-induced ICAM-1 promoter activity. The ICAM-1 promoter activity was stimulated by cotransfection with wild type PLC-gamma2, PKCalpha, c-Src, JAK1, or STAT1. An immunocomplex kinase assay showed that both IFN-gamma and TPA activated c-Src and Lyn activities and that these effects were inhibited by staurosporine and herbimycin. Thus, in NCI-H292 epithelial cells, IFN-gamma activates PLC-gamma2 via an upstream tyrosine kinase to induce activation of PKC-alpha and c-Src or Lyn, resulting in activation of STAT1alpha, and GAS in the ICAM-1 promoter, followed by initiation of ICAM-1 expression and monocyte adhesion.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

